Phreesia, Inc. (NYSE:PHR) COO Sells $43,929.45 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 1,845 shares of Phreesia stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $23.81, for a total transaction of $43,929.45. Following the completion of the sale, the chief operating officer now directly owns 774,807 shares of the company’s stock, valued at approximately $18,448,154.67. This trade represents a 0.24 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Evan Roberts also recently made the following trade(s):

• On Tuesday, April 8th, Evan Roberts sold 7,233 shares of Phreesia stock. The stock was sold at an average price of $23.85, for a total value of $172,507.05.
• On Tuesday, February 18th, Evan Roberts sold 3,519 shares of Phreesia stock. The stock was sold at an average price of $30.06, for a total transaction of $105,781.14.
• On Thursday, February 13th, Evan Roberts sold 16,005 shares of Phreesia stock. The stock was sold at an average price of $30.00, for a total value of $480,150.00.
• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total transaction of $348,175.19.

Phreesia Trading Up 0.1 %

NYSE PHR opened at $23.92 on Friday. The company’s 50-day simple moving average is $26.07 and its two-hundred day simple moving average is $24.31. Phreesia, Inc. has a one year low of $17.07 and a one year high of $30.53. The company has a market capitalization of $1.41 billion, a price-to-earnings ratio of -16.27 and a beta of 0.82. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on PHR shares. Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and upped their target price for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. DA Davidson dropped their price target on shares of Phreesia from $36.00 to $34.00 and set a “buy” rating for the company in a research note on Monday, April 14th. Canaccord Genuity Group raised their price objective on shares of Phreesia from $34.00 to $35.00 and gave the stock a “buy” rating in a research note on Thursday, March 13th. Citigroup upped their target price on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Finally, Piper Sandler restated an “overweight” rating and set a $33.00 price objective (up previously from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $31.33.

Hedge Funds Weigh In On Phreesia

A number of large investors have recently bought and sold shares of the business. State Street Corp increased its holdings in shares of Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after acquiring an additional 88,517 shares during the period. Charles Schwab Investment Management Inc. boosted its position in Phreesia by 10.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company’s stock valued at $12,415,000 after purchasing an additional 46,209 shares in the last quarter. Wesbanco Bank Inc. boosted its position in Phreesia by 76.9% during the fourth quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock valued at $1,157,000 after purchasing an additional 20,000 shares in the last quarter. Barclays PLC grew its stake in Phreesia by 83.6% in the third quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after purchasing an additional 43,225 shares during the last quarter. Finally, Franklin Resources Inc. raised its holdings in Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after purchasing an additional 42,973 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.